← Back to Search


CHF 1535 pMDI for Asthma (FORCE2 Trial)

Phase 3
Waitlist Available
Led By Steven F. Weinstein, M.D.
Research Sponsored by Chiesi Farmaceutici S.p.A.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up week 12
Awards & highlights

FORCE2 Trial Summary

This triallooks at how two drugs compare in helping people with asthma on high-dose steroids.

Who is the study for?
Adults aged 18-75 with stable asthma on medium or high-dose inhaled corticosteroids can join this trial. They must have a history of asthma for at least a year, onset before age 40, and meet specific lung function criteria. Women must use effective birth control if applicable.Check my eligibility
What is being tested?
The study is testing the effectiveness of CHF 1535 pMDI (a combination inhaler containing Beclomethasone Dipropionate/Formoterol Fumarate) against CHF 718 pMDI (Beclomethasone Dipropionate alone) in adults with asthma who are already using medium to high doses of inhaled corticosteroids.See study design
What are the potential side effects?
Potential side effects may include throat irritation, hoarseness, coughing, headaches, and possible increased risk of infections. Long-term use might affect bone density or cause eye issues like cataracts or glaucoma.

FORCE2 Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 12
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 12 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from baseline in FEV1 Area Under the Curve from 0 to 12 hours post-dose (AUC0-12h) at Week 12 calculated as the difference of the values for CHF 1535 pMDI 800/24µg total daily dose (TDD) and CHF 718 pMDI 800µg TDD.
Secondary outcome measures
Change from baseline in peak FEV1 within the first 3 hours post-dose at Week 12 calculated as the difference of the values for CHF 1535 pMDI 800/24µg TDD and CHF 718 pMDI 800µg TDD.

FORCE2 Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: CHF 1535 pMDIExperimental Treatment1 Intervention
CHF 1535 pMDI 800/24µg TDD
Group II: CHF 718 pMDIActive Control1 Intervention
CHF 718 pMDI 800µg TDD
First Studied
Drug Approval Stage
How many patients have taken this drug
Beclomethasone dipropionate
FDA approved

Find a Location

Who is running the clinical trial?

Chiesi Farmaceutici S.p.A.Lead Sponsor
198 Previous Clinical Trials
311,434 Total Patients Enrolled
69 Trials studying Asthma
229,176 Patients Enrolled for Asthma
Steven F. Weinstein, M.D.Principal InvestigatorAllergy and Asthma Specialists Medical Group and Research Center

Media Library

Beclomethasone Dipropionate (Corticosteroid) Clinical Trial Eligibility Overview. Trial Name: NCT05292586 — Phase 3
Asthma Research Study Groups: CHF 1535 pMDI, CHF 718 pMDI
Asthma Clinical Trial 2023: Beclomethasone Dipropionate Highlights & Side Effects. Trial Name: NCT05292586 — Phase 3
Beclomethasone Dipropionate (Corticosteroid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05292586 — Phase 3
Asthma Patient Testimony for trial: Trial Name: NCT05292586 — Phase 3

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the trial accept elderly participants over 80 years of age?

"This trial is accepting patients from the ages of 18 to 75. There are 117 studies for minors and 193 trials designed specifically with elderly persons in mind."

Answered by AI

Has the FDA given clearance for CHF 1535 pMDI?

"Through rigorous Phase 3 trials, our team at Power has ascertained that CHF 1535 pMDI is a safe intervention for patients. Thus, it obtained a score of 3 on the safety scale from 1 to 3."

Answered by AI

Are the criteria necessary for enrollment in this research project met by me?

"This research trial is actively enrolling up to 580 participants, aged between 18 and 75 with a diagnosis of asthma."

Answered by AI

How many sites are responsible for overseeing this clinical trial?

"At present, this clinical trial is recruiting from a total of 96 sites. Some of the cities in which these centres are located include Chandler, Encinitas and Huntington Beach; other locations can be found around the country. Choosing to register for participation at your closest site will help reduce travelling commitments."

Answered by AI

Does this clinical trial presently accept new participants?

"Affirmative. Clinicaltrials.gov affirms that this experiment, which was initially posted on October 5th 2022, is currently searching for participants. In total 580 patients are needed to be recruited from 96 distinct medical sites."

Answered by AI

What is the current enrollment number of this medical research?

"This study requires 580 eligible participants, who can conveniently enrol from Chiesi Clinical Trial Site 840895 in Chandler, Arizona or at the Chiesi Clinical Trial Site 840856 location in Encinitas, California."

Answered by AI

Who else is applying?

What state do they live in?
North Carolina
South Carolina
What site did they apply to?
Chiesi Clinical Trial Site 840861
Chiesi Clinical Trial Site 840821
Chiesi Clinical Trial Site 840811
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
How many prior treatments have patients received?

What questions have other patients asked about this trial?

How long will visits take , how frequently are visits , is it paid?
PatientReceived 2+ prior treatments

Why did patients apply to this trial?

Near to home. To better improve my asthma. I’m ok looking to supplement the income.
PatientReceived no prior treatments
Really want to get my asthma under control. I use my inhaler multiple times daily and dont have a regulator inhaler been diagnosed since age 1.
PatientReceived no prior treatments
Recent research and studies
~31 spots leftby Jun 2024